|
LCBDE术后复发性胆总管结石的诊治现状
|
Abstract:
胆总管结石是胆道系统疾病中的常见类型。腹腔镜胆总管切开取石术(Laparoscopic Common Bile Duct Exploration, LCBDE)作为一种微创手术技术,因其创伤小、恢复迅速、疼痛较轻和住院时间短等优点,已成为胆总管结石治疗的首选方案之一。然而,即便采用了LCBDE,胆总管结石的复发风险仍然存在。为了全面了解LCBDE术后胆总管结石(Common Bile Duct Stones, CBDS)的复发情况,并降低其复发率,本文将对复发性胆结石的危险因素、诊断检查方法、治疗策略以及预防措施等方面进行综述。
Common Bile Duct Stones (CBDS) is a common type of biliary system disease. Laparoscopic Common Bile Duct Exploration (LCBDE), as a minimally invasive surgical technique, has become the first choice for the treatment of common bile duct stones due to its advantages of small trauma, rapid recovery, mild pain and short hospitalization time. One of the preferred options. However, even with LCBDE, the risk of recurrence of choledocholithiasis remains. In order to comprehensively understand the recurrence of CBDS after LCBDE and reduce its recurrence rate, this article will review the risk factors, diagnostic examination methods, treatment strategies and preventive measures of recurrent CBDS.
[1] | Wang, X., Yu, W., Jiang, G., Li, H., Li, S., Xie, L., et al. (2024) Global Epidemiology of Gallstones in the 21st Century: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 22, 1586-1595. https://doi.org/10.1016/j.cgh.2024.01.051 |
[2] | Jaruvongvanich, V., Sanguankeo, A. and Upala, S. (2016) Significant Association between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences, 61, 2389-2396. https://doi.org/10.1007/s10620-016-4125-2 |
[3] | Wang, Y., Lu, J., Wen, N., Nie, G., Peng, D., Xiong, X., et al. (2022) The Role of Diet and Nutrition Related Indicators in Biliary Diseases: An Umbrella Review of Systematic Review and Meta-Analysis. Nutrition & Metabolism, 19, Article No. 51. https://doi.org/10.1186/s12986-022-00677-1 |
[4] | Das, S., Jha, A.K. and Kumar, M. (2023) Laparoscopic Common Bile Duct Exploration in Cases of Common Bile Duct Stones: Can LCBDE Replace ERCP as First Line Treatment. The American Journal of Surgery, 226, Article 290. https://doi.org/10.1016/j.amjsurg.2023.03.006 |
[5] | 姚康, 童朝刚. LC联合LCBDE+T管引流术后胆总管结石复发的相关危险因素分析[J]. 医学信息(上旬刊), 2022, 35(5): 98-100, 120. |
[6] | Deng, F., Zhou, M., Liu, P., Hong, J., Li, G., Zhou, X., et al. (2019) Causes Associated with Recurrent Choledocholithiasis Following Therapeutic Endoscopic Retrograde Cholangiopancreatography: A Large Sample Sized Retrospective Study. World Journal of Clinical Cases, 7, 1028-1037. https://doi.org/10.12998/wjcc.v7.i9.1028 |
[7] | Wen, N., Wang, Y., Cai, Y., Nie, G., Yang, S., Wang, S., et al. (2023) Risk Factors for Recurrent Common Bile Duct Stones: A Systematic Review and Meta-analysis. Expert Review of Gastroenterology & Hepatology, 17, 937-947. https://doi.org/10.1080/17474124.2023.2242784 |
[8] | Yoo, E.S., Yoo, B.M., Kim, J.H., Hwang, J.C., Yang, M.J., Lee, K.M., et al. (2018) Evaluation of Risk Factors for Recurrent Primary Common Bile Duct Stone in Patients with Cholecystectomy. Scandinavian Journal of Gastroenterology, 53, 466-470. https://doi.org/10.1080/00365521.2018.1438507 |
[9] | Song, M.E., Chung, M.J., Lee, D., Oh, T.G., Park, J.Y., Bang, S., et al. (2016) Cholecystectomy for Prevention of Recurrence after Endoscopic Clearance of Bile Duct Stones in Korea. Yonsei Medical Journal, 57, 132-137. https://doi.org/10.3349/ymj.2016.57.1.132 |
[10] | Thistle, J.L. (1998) Pathophysiology of Bile Duct Stones. World Journal of Surgery, 22, 1114-1118. https://doi.org/10.1007/s002689900529 |
[11] | Wang, H., He, Y., Dong, S., Zhong, W., Tao, P., Yang, S., et al. (2023) Recurrence of Common Bile Duct Stones after Choledocholithotomy in Elderly Patients: Risk Factor Analysis and Clinical Prediction Model Development. Frontiers in Medicine, 10, Article 1239902. https://doi.org/10.3389/fmed.2023.1239902 |
[12] | Parra-Membrives, P., Martínez-Baena, D., Lorente-Herce, J.M., Jiménez-Riera, G. and Sánchez-Gálvez, M.Á. (2019) Recurrencia de coledocolitiasis tras exploración laparoscópica de la vía biliar principal. Cirugía Española, 97, 336-342. https://doi.org/10.1016/j.ciresp.2019.02.012 |
[13] | Li, Y., Wang, M., Du, W., Qi, L., Liu, X. and Fan, X. (2024) The Correlation between Urinary Iodine Levels and Gallstone Risk: Elevated Iodine Intake Linked to Gallstone Occurrence. Frontiers in Nutrition, 11, Article 1412814. https://doi.org/10.3389/fnut.2024.1412814 |
[14] | Kube, I., Tardio, L.B., Hofmann, U., Ghallab, A., Hengstler, J.G., Führer, D., et al. (2021) Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids. Thyroid, 31, 973-984. https://doi.org/10.1089/thy.2020.0636 |
[15] | Wang, Y., Yu, X., Zhao, Q., Zheng, S., Qing, W., Miao, C., et al. (2016) Thyroid Dysfunction, Either Hyper or Hypothyroidism, Promotes Gallstone Formation by Different Mechanisms. Journal of Zhejiang University-SCIENCE B, 17, 515-525. https://doi.org/10.1631/jzus.b1500210 |
[16] | Nakano, S., Suzuki, M., Haruna, H., Yamataka, A. and Shimizu, T. (2019) Gallstone Formation Due to Rapid Weight Loss through Hyperthyroidism. Journal of Pediatric Endocrinology and Metabolism, 32, 1395-1398. https://doi.org/10.1515/jpem-2019-0149 |
[17] | Liu, J., Liu, L., Jia, Q., Zhang, X., Jin, X. and Shen, H. (2019) Effects of Excessive Iodine Intake on Blood Glucose, Blood Pressure, and Blood Lipids in Adults. Biological Trace Element Research, 192, 136-144. https://doi.org/10.1007/s12011-019-01668-9 |
[18] | Shen, X., Yang, L., Liu, Y., Zhang, X., Cai, P., Huang, J., et al. (2023) Associations between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional Study. Frontiers in Endocrinology, 14, Article 1153462. https://doi.org/10.3389/fendo.2023.1153462 |
[19] | Zhang, Y., Sun, L., Wang, X. and Chen, Z. (2022) The Association between Hypertension and the Risk of Gallstone Disease: A Cross-Sectional Study. BMC Gastroenterology, 22, Article No. 138. https://doi.org/10.1186/s12876-022-02149-5 |
[20] | Wu, Y., Xu, C.J. and Xu, S.F. (2021) Advances in Risk Factors for Recurrence of Common Bile Duct Stones. International Journal of Medical Sciences, 18, 1067-1074. https://doi.org/10.7150/ijms.52974 |
[21] | Li, S., Su, B., Chen, P. and Hao, J. (2018) Risk Factors for Recurrence of Common Bile Duct Stones after Endoscopic Biliary Sphincterotomy. Journal of International Medical Research, 46, 2595-2605. https://doi.org/10.1177/0300060518765605 |
[22] | Liu, F., Wang, Z., Li, M., Zhang, X., Cai, F., Wang, X., et al. (2024) Characterization of Biliary and Duodenal Microbiota in Patients with Primary and Recurrent Choledocholithiasis. Health Information Science and Systems, 12, Article No. 29. https://doi.org/10.1007/s13755-023-00267-2 |
[23] | Li, Y., Tan, W., Wu, J., Huang, Z., Shang, Y., Liang, B., et al. (2022) Microbiologic Risk Factors of Recurrent Choledocholithiasis Post-Endoscopic Sphincterotomy. World Journal of Gastroenterology, 28, 1257-1271. https://doi.org/10.3748/wjg.v28.i12.1257 |
[24] | Park, B.K., Seo, J.H., Jeon, H.H., Choi, J.W., Won, S.Y., Cho, Y.S., et al. (2017) A Nationwide Population-Based Study of Common Bile Duct Stone Recurrence after Endoscopic Stone Removal in Korea. Journal of Gastroenterology, 53, 670-678. https://doi.org/10.1007/s00535-017-1419-x |
[25] | 叶万平, 曾安祥, 曾德辉, 等. ERCP、MRCP、CT、B超对胆总管结石的诊断价值分析[J]. 中外医疗, 2020, 39(34): 187-189. |
[26] | 李宁, 慕明堂. MRCP与腹部CT检查在肝外胆结石中的临床价值比较[J]. 深圳中西医结合杂志, 2023, 33(3): 64-66. |
[27] | Breidert, M., Weber, M. and Wildi, S. (2020) Unusual Aspect of a Choledocholithiasis. Gastroenterology, 159, 1660-1661. https://doi.org/10.1053/j.gastro.2020.05.072 |
[28] | Williams, E.J., Green, J., Beckingham, I., Parks, R., Martin, D. and Lombard, M. (2008) Guidelines on the Management of Common Bile Duct Stones (CBDs). Gut, 57, 1004-1021. https://doi.org/10.1136/gut.2007.121657 |
[29] | Caddy, G.R. and Tham, T.C.K. (2006) Symptoms, Diagnosis and Endoscopic Management of Common Bile Duct Stones. Best Practice & Research Clinical Gastroenterology, 20, 1085-1101. https://doi.org/10.1016/j.bpg.2006.03.002 |
[30] | Mo, L., Hwang, M., Yueh, S., Yang, J. and Lin, C. (1988) Percutaneous Transhepatic Choiedochoscopic Electrohydraulic Lithotripsy (PTCS-EHL) of Common Bile Duct Stones. Gastrointestinal Endoscopy, 34, 122-125. https://doi.org/10.1016/s0016-5107(88)71276-6 |
[31] | Wang, P., Sun, B., Huang, B., Xie, J., Liu, Y., Zhu, C., et al. (2016) Comparison between Percutaneous Transhepatic Rigid Cholangioscopic Lithotripsy and Conventional Percutaneous Transhepatic Cholangioscopic Surgery for Hepatolithiasis Treatment. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 26, 54-59. https://doi.org/10.1097/sle.0000000000000222 |
[32] | Yildirim, A.E. (2019) Optimal Dilation Time for Combined Small Endoscopic Sphincterotomy and Balloon Dilation for Common Bile Duct Stones: A Multicentre, Single-Blinded, Randomised Controlled Trial. The Turkish Journal of Gastroenterology, 30, 662-663. https://doi.org/10.5152/tjg.2019.240519 |
[33] | Wandling, M.W., Hungness, E.S., Pavey, E.S., Stulberg, J.J., Schwab, B., Yang, A.D., et al. (2016) Nationwide Assessment of Trends in Choledocholithiasis Management in the United States from 1998 to 2013. JAMA Surgery, 151, 1125-1130. https://doi.org/10.1001/jamasurg.2016.2059 |
[34] | Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J., et al. (2017) Role of Endoscopy in Primary Sclerosing Cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy, 49, 588-608. https://doi.org/10.1055/s-0043-107029 |
[35] | Hussein, M., Everson, M. and Haidry, R. (2021) Esophageal Squamous Dysplasia and Cancer: Is Artificial Intelligence Our Best Weapon? Best Practice & Research Clinical Gastroenterology, 52, Article ID: 101723. https://doi.org/10.1016/j.bpg.2020.101723 |
[36] | Arribas Anta, J. and Dinis-Ribeiro, M. (2021) Early Gastric Cancer and Artificial Intelligence: Is It Time for Population Screening? Best Practice & Research Clinical Gastroenterology, 52, Article ID: 101710. https://doi.org/10.1016/j.bpg.2020.101710 |
[37] | Piccirelli, S., Milluzzo, S.M., Bizzotto, A., Cesaro, P., Pecere, S. and Spada, C. (2021) Small Bowel Capsule Endoscopy and Artificial Intelligence: First or Second Reader? Best Practice & Research Clinical Gastroenterology, 52, Article ID: 101742. https://doi.org/10.1016/j.bpg.2021.101742 |
[38] | Antonelli, G., Badalamenti, M., Hassan, C. and Repici, A. (2021) Impact of Artificial Intelligence on Colorectal Polyp Detection. Best Practice & Research Clinical Gastroenterology, 52, Article ID: 101713. https://doi.org/10.1016/j.bpg.2020.101713 |
[39] | Jovanovic, P., Salkic, N.N. and Zerem, E. (2014) Artificial Neural Network Predicts the Need for Therapeutic ERCP in Patients with Suspected Choledocholithiasis. Gastrointestinal Endoscopy, 80, 260-268. https://doi.org/10.1016/j.gie.2014.01.023 |
[40] | Huang, L., Xu, Y., Chen, J., Liu, F., Wu, D., Zhou, W., et al. (2022) An Artificial Intelligence Difficulty Scoring System for Stone Removal during ERCP: A Prospective Validation. Endoscopy, 55, 4-11. https://doi.org/10.1055/a-1850-6717 |
[41] | Sun, X. (2003) Prospective Study of Scoring System in Selective Intraoperative Cholangiography during Laparoscopic Cholecystectomy. World Journal of Gastroenterology, 9, 865-867. https://doi.org/10.3748/wjg.v9.i4.865 |
[42] | Dumonceau, J., Kapral, C., Aabakken, L., Papanikolaou, I.S., Tringali, A., Vanbiervliet, G., et al. (2019) ERCP-Related Adverse Events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 52, 127-149. https://doi.org/10.1055/a-1075-4080 |
[43] | Archibugi, L., Ciarfaglia, G., Cárdenas-Jaén, K., Poropat, G., Korpela, T., Maisonneuve, P., et al. (2023) Machine Learning for the Prediction of Post-ERCP Pancreatitis Risk: A Proof-of-Concept Study. Digestive and Liver Disease, 55, 387-393. https://doi.org/10.1016/j.dld.2022.10.005 |
[44] | Kriegermeier, A. and Green, R. (2020) Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies. Frontiers in Medicine, 7, Article 149. https://doi.org/10.3389/fmed.2020.00149 |
[45] | Paumgartner, G. and Beuers, U. (2002) Ursodeoxycholic Acid in Cholestatic Liver Disease: Mechanisms of Action and Therapeutic Use Revisited. Hepatology, 36, 525-531. https://doi.org/10.1053/jhep.2002.36088 |
[46] | Ward, A., Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. (1984) Ursodeoxycholic Acid: A Review of Its Pharmacological Properties and Therapeutic Efficacy. Drugs, 27, 95-131. https://doi.org/10.2165/00003495-198427020-00001 |
[47] | Yuan, W., Zhang, Z., Pan, Q., Mao, B. and Yuan, T. (2024) Risk Factors for Recurrence of Common Bile Duct Stones after Surgical Treatment and Effect of Ursodeoxycholic Acid Intervention. World Journal of Gastrointestinal Surgery, 16, 103-112. https://doi.org/10.4240/wjgs.v16.i1.103 |
[48] | Huang, L., Li, S., Chen, J., Zhu, Y., Lan, K., Zeng, L., et al. (2023) Efficacy and Safety of Ursodeoxycholic Acid in Children with Cholestasis: A Systematic Review and Meta-Analysis. PLOS ONE, 18, e0280691. https://doi.org/10.1371/journal.pone.0280691 |
[49] | Akiyama, S., Imamura, T., Tamura, T., Koizumi, Y., Koyama, R., Takeuchi, K., et al. (2014) Recurrent Common Bile Duct Stones Composed of Ursodeoxycholic Acid: A Report of Four Cases. Internal Medicine, 53, 2489-2492. https://doi.org/10.2169/internalmedicine.53.2886 |
[50] | Matsui, H., Yoshida, T., Homma, S., Ichikawa, N., Emoto, S., Miyaoka, Y., et al. (2021) Ursodeoxycholic Acid Triggers Primary Enterolith Growth in a Crohn’s Disease Patient with Jejunal Stenosis. Journal of the Anus, Rectum and Colon, 5, 433-438. https://doi.org/10.23922/jarc.2021-017 |